抗氧化剂、氧化损伤与心血管健康相关健康声称的科学要求指南：（修订版1）
Guidance for the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health: (Revision 1).
作者信息
Turck Dominique, Bresson Jean-Louis, Burlingame Barbara, Dean Tara, Fairweather-Tait Susan, Heinonen Marina, Hirsch-Ernst Karen Ildico, Mangelsdorf Inge, McArdle Harry J, Naska Androniki, Neuhäuser-Berthold Monika, Nowicka Grażyna, Pentieva Kristina, Sanz Yolanda, Sjödin Anders, Stern Martin, Tomé Daniel, Van Loveren Henk, Vinceti Marco, Willatts Peter, Martin Ambroise, Strain John Joseph, Heng Leng, Valtueña Martínez Silvia, Siani Alfonso
出版信息
EFSA J. 2018 Jan 19;16(1):e05136. doi: 10.2903/j.efsa.2018.5136. eCollection 2018 Jan.
Abstract
EFSA asked the Panel on Dietetic Products, Nutrition and Allergies (NDA) to update the guidance on the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health published in 2011. The update takes into accounts experiences gained with evaluation of additional health claim applications related to antioxidants, oxidative damage and cardiovascular health, and the information collected from a Grant launched in 2014. This guidance is intended to assist applicants in preparing applications for the authorisation of health claims related to the antioxidants, oxidative damage and cardiovascular health. The document was subject to public consultation (from 12 July to 3 September 2017). This document supersedes the guidance on the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health published in 2011. It is intended that the guidance will be further updated as appropriate in the light of experience gained from the evaluation of health claims.
摘要
欧洲食品安全局要求营养产品、营养和过敏症专家委员会（NDA）更新2011年发布的关于抗氧化剂、氧化损伤和心血管健康相关健康声明科学要求的指南。此次更新考虑了在评估与抗氧化剂、氧化损伤和心血管健康相关的其他健康声明申请过程中获得的经验，以及从2014年启动的一项资助项目中收集的信息。本指南旨在协助申请人准备与抗氧化剂、氧化损伤和心血管健康相关健康声明的授权申请。该文件进行了公众咨询（2017年7月12日至9月3日）。本文件取代了2011年发布的关于抗氧化剂、氧化损伤和心血管健康相关健康声明科学要求的指南。预计将根据健康声明评估中获得的经验，视情况进一步更新本指南。
相似文献
1
Guidance for the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health: (Revision 1).抗氧化剂、氧化损伤与心血管健康相关健康声称的科学要求指南：（修订版1）
EFSA J. 2018 Jan 19;16(1):e05136. doi: 10.2903/j.efsa.2018.5136. eCollection 2018 Jan.
2
Guidance on the scientific requirements for health claims related to muscle function and physical performance: (Revision 1).与肌肉功能和身体表现相关的健康声称的科学要求指南：（修订版1）
EFSA J. 2018 Oct 30;16(10):e05434. doi: 10.2903/j.efsa.2018.5434. eCollection 2018 Oct.
3
Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 2).健康声明申请编制与提交的科学和技术指南（修订版2）
EFSA J. 2017 Jan 31;15(1):e04680. doi: 10.2903/j.efsa.2017.4680. eCollection 2017 Jan.
4
General scientific guidance for stakeholders on health claim applications (Revision 1).利益相关者关于健康声称申请的一般科学指南（修订版1）。
EFSA J. 2021 Mar 26;19(3):e06553. doi: 10.2903/j.efsa.2021.6553. eCollection 2021 Mar.
5
Scientific and technical guidance for the preparation and presentation of an application for authorisation of an infant and/or follow-on formula manufactured from protein hydrolysates.关于由蛋白质水解物制成的婴儿配方奶粉和/或后续配方奶粉授权申请的编制和提交的科学和技术指南。
EFSA J. 2017 May 11;15(5):e04779. doi: 10.2903/j.efsa.2017.4779. eCollection 2017 May.
6
Scientific substantiation of health claims in the EU.欧盟健康声称的科学依据。
Proc Nutr Soc. 2012 Feb;71(1):120-6. doi: 10.1017/S0029665111003168. Epub 2011 Sep 20.
7
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health.根据欧盟法规1924/2006提出的、在预防氧化损伤和心血管健康框架下的健康声明所宣称的功效、结果变量及测量方法。
Nutr Metab Cardiovasc Dis. 2017 Jun;27(6):473-503. doi: 10.1016/j.numecd.2017.01.008. Epub 2017 Feb 13.
8
Vitamin C and protection of DNA, proteins and lipids from oxidative damage: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006.维生素C与DNA、蛋白质及脂质的抗氧化损伤保护作用：依据欧盟第1924/2006号法规第14条对一项健康声明的评估
EFSA J. 2017 Jan 27;15(1):e04685. doi: 10.2903/j.efsa.2017.4685. eCollection 2017 Jan.
9
Xanthohumol in XERME, a xanthohumol-enriched roasted malt extract, and protection of DNA from oxidative damage: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.XERME（一种富含黄腐酚的烘焙麦芽提取物）中的黄腐酚以及DNA免受氧化损伤的保护作用：根据欧盟第1924/2006号法规第13(5)条对一项健康声明的评估
EFSA J. 2018 Mar 13;16(3):e05192. doi: 10.2903/j.efsa.2018.5192. eCollection 2018 Mar.
10
The EFSA health claims 'learning experience'.EFSA 健康声称“学习经验”。
Int J Food Sci Nutr. 2012 Mar;63 Suppl 1:14-6. doi: 10.3109/09637486.2011.633899. Epub 2011 Nov 16.
引用本文的文献
1
From Quantity to Reactivity: Advancing Kinetic-Based Antioxidant Testing Methods for Natural Compounds and Food Applications.从数量到反应活性：推进基于动力学的天然化合物和食品应用抗氧化剂测试方法
Compr Rev Food Sci Food Saf. 2025 Jul;24(4):e70229. doi: 10.1111/1541-4337.70229.
2
Antioxidant Effects of SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic (CKM) Syndrome.钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂对心血管-肾脏-代谢（CKM）综合征的抗氧化作用
Antioxidants (Basel). 2025 Jun 9;14(6):701. doi: 10.3390/antiox14060701.
3
Phenolic compounds naturally present in olive oil and lowering of blood LDL-cholesterol and systolic blood pressure, therefore reducing the risk of coronary heart disease: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006.橄榄油中天然存在的酚类化合物与降低血液低密度脂蛋白胆固醇及收缩压，从而降低冠心病风险：依据欧盟第1924/2006号法规第14条对一项健康声明的评估
EFSA J. 2025 May 23;23(5):e9470. doi: 10.2903/j.efsa.2025.9470. eCollection 2025 May.
4
Olive oil polyphenols and the maintenance of normal HDL-cholesterol concentrations: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.橄榄油多酚与正常高密度脂蛋白胆固醇浓度的维持：依据欧盟第1924/2006号法规第13(5)条对一项健康声明的评估
EFSA J. 2025 May 2;23(5):e9372. doi: 10.2903/j.efsa.2025.9372. eCollection 2025 May.
5
Prebiotics in food and dietary supplements: a roadmap to EU health claims.食品和膳食补充剂中的益生元：通往欧盟健康声称的路线图。
Gut Microbes. 2024 Jan-Dec;16(1):2428848. doi: 10.1080/19490976.2024.2428848. Epub 2024 Nov 15.
6
Analytical Determination of Squalene in Extra Virgin Olive Oil and Olive Processing By-Products, and Its Valorization as an Ingredient in Functional Food-A Critical Review.分析测定特级初榨橄榄油和橄榄油加工副产物中的角鲨烯及其作为功能性食品成分的增值——综述评论。
Molecules. 2024 Nov 3;29(21):5201. doi: 10.3390/molecules29215201.
7
Exploitation of Natural By-Products for the Promotion of Healthy Outcomes in Humans: Special Focus on Antioxidant and Anti-Inflammatory Mechanisms and Modulation of the Gut Microbiota.利用天然副产品促进人类健康成果：特别关注抗氧化和抗炎机制以及肠道微生物群的调节。
Antioxidants (Basel). 2024 Jun 29;13(7):796. doi: 10.3390/antiox13070796.
8
Joselito® and lowering of LDL-cholesterol concentration, blood pressure, and reduction of coronary heart disease risk: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006.乔塞利托®与低密度脂蛋白胆固醇浓度降低、血压降低以及冠心病风险降低：依据欧盟第1924/2006号法规第14条对一项健康声明的评估
EFSA J. 2024 Jul 4;22(7):e8862. doi: 10.2903/j.efsa.2024.8862. eCollection 2024 Jul.
9
A Review of Foods of Plant Origin as Sources of Vitamins with Proven Activity in Oxidative Stress Prevention according to EFSA Scientific Evidence.根据 EFSA 的科学证据，综述植物源食物作为具有抗氧化应激预防活性的维生素来源。
Molecules. 2023 Oct 25;28(21):7269. doi: 10.3390/molecules28217269.
10
The beneficial effect of sulforaphane on platelet responsiveness during caloric load: a single-intake, double-blind, placebo-controlled, crossover trial in healthy participants.萝卜硫素对热量负荷期间血小板反应性的有益作用：一项针对健康参与者的单剂量、双盲、安慰剂对照、交叉试验。
Front Nutr. 2023 Jul 6;10:1204561. doi: 10.3389/fnut.2023.1204561. eCollection 2023.
本文引用的文献
1
General scientific guidance for stakeholders on health claim applications (Revision 1).利益相关者关于健康声称申请的一般科学指南（修订版1）。
EFSA J. 2021 Mar 26;19(3):e06553. doi: 10.2903/j.efsa.2021.6553. eCollection 2021 Mar.
2
Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 2).健康声明申请编制与提交的科学和技术指南（修订版2）
EFSA J. 2017 Jan 31;15(1):e04680. doi: 10.2903/j.efsa.2017.4680. eCollection 2017 Jan.
3
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.2016年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南。
Eur Heart J. 2016 Oct 14;37(39):2999-3058. doi: 10.1093/eurheartj/ehw272. Epub 2016 Aug 27.
4
Challenges in standardization of blood pressure measurement at the population level.人群层面血压测量标准化面临的挑战。
BMC Med Res Methodol. 2015 Apr 10;15:33. doi: 10.1186/s12874-015-0020-3.
5
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2013年欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）动脉高血压管理指南：欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）动脉高血压管理特别工作组
Eur Heart J. 2013 Jul;34(28):2159-219. doi: 10.1093/eurheartj/eht151. Epub 2013 Jun 14.
6
Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH.光透射聚集测定标准化建议：SSC/ISTH血小板生理小组委员会工作小组的共识
J Thromb Haemost. 2013 Apr 10. doi: 10.1111/jth.12231.
7
Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity.使用颈股脉搏波速度在日常实践中测量主动脉僵硬度的专家共识文件。
J Hypertens. 2012 Mar;30(3):445-8. doi: 10.1097/HJH.0b013e32834fa8b0.
8
Postprandial lipemia and cardiovascular disease risk: Interrelationships between dietary, physiological and genetic determinants.餐后血脂异常与心血管疾病风险：饮食、生理和遗传决定因素之间的相互关系。
Atherosclerosis. 2012 Jan;220(1):22-33. doi: 10.1016/j.atherosclerosis.2011.08.012. Epub 2011 Sep 9.
9
Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement.非空腹和餐后甘油三酯的评估和临床相关性：专家小组声明。
Curr Vasc Pharmacol. 2011 May;9(3):258-70. doi: 10.2174/157016111795495549.
10
Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis.餐后甘油三酯检测在健康受试者中的诊断价值：荟萃分析。
Curr Vasc Pharmacol. 2011 May;9(3):271-80. doi: 10.2174/157016111795495530.
Zotero 插件